BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 1644510)

  • 1. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family physician attitudes about prescribing using a drug formulary.
    Suggs LS; Raina P; Gafni A; Grant S; Skilton K; Fan A; Szala-Meneok K
    BMC Fam Pract; 2009 Oct; 10():69. PubMed ID: 19835601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the appropriateness of physician prescribing.
    Lexchin J
    Int J Health Serv; 1998; 28(2):253-67. PubMed ID: 9595343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pills that ate your profits.
    Meyer H
    Hosp Health Netw; 1998 Feb; 72(3):18-22. PubMed ID: 9483145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a general practice group intervention on prescribing costs and patterns.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
    Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R
    J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of therapeutic alternatives: physicians' knowledge.
    Griswold MW; Briceland LL; Lesar TS
    Ann Pharmacother; 1996; 30(7-8):882-3. PubMed ID: 8826578
    [No Abstract]   [Full Text] [Related]  

  • 11. Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting.
    Fortess EE; Soumerai SB; McLaughlin TJ; Ross-Degnan D
    J Am Geriatr Soc; 2001 Jun; 49(6):793-7. PubMed ID: 11454120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access.
    Burden AM; Tadrous M; Calzavara A; Cadarette SM
    Osteoporos Int; 2015 May; 26(5):1525-33. PubMed ID: 25603794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes.
    King MA; Roberts MS
    Pharm World Sci; 2007 Feb; 29(1):39-42. PubMed ID: 17268937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of standardized patients to assess between-physician variations in resource utilization.
    McLeod PJ; Tamblyn RM; Gayton D; Grad R; Snell L; Berkson L; Abrahamowicz M
    JAMA; 1997 Oct; 278(14):1164-8. PubMed ID: 9326476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New weightings for analysing prescribing in general practice.
    Purves I; Edwards C
    BMJ; 1993 Oct; 307(6911):1070. PubMed ID: 8251799
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic constraints and prescribing patterns in New Zealand.
    Kellaway GS
    Pharmacoeconomics; 1992 Sep; 2(3):189-97. PubMed ID: 10147009
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing.
    Palmer K
    Practitioner; 1990 Oct; 234(1495):888-90. PubMed ID: 2131447
    [No Abstract]   [Full Text] [Related]  

  • 20. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.